Scientists are reporting on the first phase 1 study of the JAK2 inhibitor ruxolitinib in CMML patients.
SOURCE: Top Health News — ScienceDaily – Read entire story here.
Related posts:
- Growing interest: School-grown vegetables increase salad selection If kids grow vegetables, they're more likely to eat them. A new study shows that when garden grown vegetables were slipped into school salads, kids were over four times as likely to take a salad. ...
- ‘Green chemistry’ to quantify the components of cosmetics There are 10,000 components that can be used to make cosmetics. These components have to be monitored to guarantee consumer safety. Scientists have now developed three 'green' analytical methods to simultaneously analyze various components used in cosmetics. In these methods very little solvent is used and very little residue is produced in comparison with other analytical techniques. ...
- Many children with asthma have reaction to peanuts, but do not know it In recent years and months, peanut allergies in children have been in the news frequently, as scientists reveal new insights into why more and more children are developing them and what can be done to avoid them. However, until now, few have studied the connection between peanut allergy and childhood asthma. ...
- Snacking on protein can improve appetite control, diet quality in teens Although eating high-protein, afternoon snacks can aid appetite control in adults, little information exists to guide parents on what types of snacks might benefit their adolescent children. Now, researchers have found that afternoon snacking, particularly on high-protein-soy foods, reduces afternoon appetite, delays subsequent eating and reduces unhealthy evening snacking in teenagers. ...
- Anticoagulant medications: Newer, easier to manage medications may not always be the best choice If you are over age 75, and taking an anticoagulant, the old standard may be the gold standard, Mayo Clinic researchers and collaborators have determined. ...
